Viewing Study NCT03316794


Ignite Creation Date: 2025-12-25 @ 1:39 AM
Ignite Modification Date: 2026-02-25 @ 2:41 AM
Study NCT ID: NCT03316794
Status: TERMINATED
Last Update Posted: 2018-12-17
First Post: 2017-10-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of SC-005 in Subjects With Triple Negative Breast Cancer (TNBC)
Sponsor: AbbVie
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Triple Negative Breast Cancer View
None Cancer View
None Breast Cancer View
None Maximum tolerated dose (MTD) View
None Pharmacokinetics View